110 related articles for article (PubMed ID: 6368232)
1. Captopril in congestive heart failure resistant to other vasodilators.
Fouad FM; El-Tobgi S; Tarazi RC; Bravo EL; Hart NJ; Shirey EK; Lim J
Eur Heart J; 1984 Jan; 5(1):47-54. PubMed ID: 6368232
[TBL] [Abstract][Full Text] [Related]
2. [Enhancement of the effect of captopril in the 1st 48 hours of treating refractory heart failure. A comparison with intravenous trinitrine].
Le Pailleur C; Baubion N; Metzger JP; Heulin A; Vacheron A; Di Matteo J
Arch Mal Coeur Vaiss; 1984 Jun; 77(6):700-6. PubMed ID: 6431936
[TBL] [Abstract][Full Text] [Related]
3. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
5. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
[TBL] [Abstract][Full Text] [Related]
6. Long-term control of congestive heart failure with captopril.
Fouad FM; Tarazi RC; Bravo EL; Hart NJ; Castle LW; Salcedo EE
Am J Cardiol; 1982 Apr; 49(6):1489-96. PubMed ID: 6803563
[TBL] [Abstract][Full Text] [Related]
7. Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Sharpe DN; Coxon R
Aust N Z J Med; 1982 Oct; 12(5):483-8. PubMed ID: 6758746
[TBL] [Abstract][Full Text] [Related]
8. Postural hypotension during tilt with chronic captopril and diuretic therapy of severe congestive heart failure.
Cody RJ; Franklin KW; Laragh JH
Am Heart J; 1982 Apr; 103(4 Pt 1):480-4. PubMed ID: 7039281
[TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of congestive heart failure with captopril.
Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
[TBL] [Abstract][Full Text] [Related]
10. Acute and long-term haemodynamic and neurohumoral response to nisoldipine vs captopril in patients with heart failure: a randomized double-blind study.
Schofer J; Hobuss M; Aschenberg W; Tews A
Eur Heart J; 1990 Aug; 11(8):712-21. PubMed ID: 1975780
[TBL] [Abstract][Full Text] [Related]
11. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic and clinical effects of captopril in congestive heart failure].
Galiè N; Magelli C; Ribani MA; Bassein L; Sanguinetti M; Magnani B
G Ital Cardiol; 1985 Jan; 15(1):70-9. PubMed ID: 3891488
[TBL] [Abstract][Full Text] [Related]
14. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
15. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
[TBL] [Abstract][Full Text] [Related]
16. Combined vasodilator therapy for chronic congestive heart failure.
Cody RJ; Franklin KW; Laragh JH
Am Heart J; 1983 Apr; 105(4):575-80. PubMed ID: 6340448
[TBL] [Abstract][Full Text] [Related]
17. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
Silberbauer K; Punzengruber C; Sinzinger H
Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
[TBL] [Abstract][Full Text] [Related]
18. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
Mettauer B; Rouleau JL; Bichet D; Kortas C; Manzini C; Tremblay G; Chatterjee K
Circulation; 1986 Mar; 73(3):492-502. PubMed ID: 3512121
[TBL] [Abstract][Full Text] [Related]
19. Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure.
Elkayam U; Roth A; Hsueh W; Weber L; Freidenberger L; Rahimtoola SH
Am Heart J; 1986 Jun; 111(6):1130-8. PubMed ID: 2872793
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of captopril in patients with severe chronic heart failure.
LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
